USS Investment Management Ltd raised its position in iRhythm Technologies (NASDAQ:IRTC – Free Report) by 84.9% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 197,729 shares of the company’s stock after purchasing an additional 90,772 shares during the quarter. USS Investment Management Ltd’s holdings in iRhythm Technologies were worth $22,465,000 at the end of the most recent quarter.
A number of other institutional investors have also recently added to or reduced their stakes in the business. Rothschild Investment LLC lifted its stake in shares of iRhythm Technologies by 170.0% in the 3rd quarter. Rothschild Investment LLC now owns 216 shares of the company’s stock valued at $25,000 after purchasing an additional 136 shares during the last quarter. Versant Capital Management Inc boosted its holdings in iRhythm Technologies by 123.2% in the third quarter. Versant Capital Management Inc now owns 221 shares of the company’s stock worth $25,000 after purchasing an additional 122 shares in the last quarter. Global Retirement Partners LLC increased its position in iRhythm Technologies by 5,450.0% during the third quarter. Global Retirement Partners LLC now owns 222 shares of the company’s stock worth $25,000 after buying an additional 218 shares during the last quarter. Covestor Ltd increased its position in iRhythm Technologies by 44.8% during the third quarter. Covestor Ltd now owns 417 shares of the company’s stock worth $47,000 after buying an additional 129 shares during the last quarter. Finally, Harbor Investment Advisory LLC acquired a new position in iRhythm Technologies during the second quarter worth $50,000.
Insiders Place Their Bets
In related news, Director Abhijit Talwalkar purchased 7,900 shares of the firm’s stock in a transaction on Thursday, November 19th. The shares were bought at an average cost of $96.67 per share, for a total transaction of $763,693.00. Following the transaction, the director directly owned 7,900 shares of the company’s stock, valued at approximately $763,693. This trade represents a ? increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 0.98% of the stock is currently owned by company insiders.
Analyst Ratings Changes
Several equities analysts have weighed in on the company. Stephens cut their target price on iRhythm Technologies from $160.00 to $120.00 and set an “overweight” rating on the stock in a report on Wednesday, November 11th. Piper Sandler decreased their price target on iRhythm Technologies from $160.00 to $150.00 and set an “overweight” rating for the company in a research note on Friday, November 6th. Weiss Ratings lowered iRhythm Technologies from a “sell (d-)” rating to a “sell (e+)” rating in a report on Thursday, November 12th. BTIG Research decreased their target price on iRhythm Technologies from $185.00 to $170.00 and set a “buy” rating for the company in a research report on Friday, November 6th. Finally, Wells Fargo & Company lowered their price target on iRhythm Technologies from $150.00 to $135.00 and set an “overweight” rating on the stock in a report on Friday, November 6th. One analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, iRhythm Technologies has a consensus rating of “Moderate Buy” and a consensus target price of $164.07.
View Our Latest Stock Analysis on IRTC
iRhythm Technologies Stock Up 0.5%
IRTC opened at $94.72 on Friday. iRhythm Technologies has a 1-year low of $82.85 and a 1-year high of $192.47. The company has a current ratio of 3.57, a quick ratio of 3.45 and a debt-to-equity ratio of 3.68. The stock has a market capitalization of $3.18 billion, a price-to-earnings ratio of -80.96 and a beta of 1.39. The business has a 50 day moving average of $109.28 and a 200-day moving average of $118.36.
iRhythm Technologies (NASDAQ:IRTC – Get Free Report) last announced its earnings results on Thursday, November 5th. The company reported $0.82 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.02 by $0.80. iRhythm Technologies had a negative net margin of 4.52% and a positive return on equity of 26.88%. The business had revenue of $221.59 million for the quarter, compared to analyst estimates of $222.23 million. During the same quarter in the previous year, the firm posted ($0.06) earnings per share. iRhythm Technologies’s revenue was up 14.9% compared to the same quarter last year. As a group, sell-side analysts anticipate that iRhythm Technologies will post 0.79 earnings per share for the current year.
iRhythm Technologies announced that its board has authorized a stock buyback plan on Wednesday, November 11th that authorizes the company to repurchase $200 million in outstanding shares. This repurchase authorization authorizes the company to buy up to 6.7% of its shares through open market purchases. Stock repurchase plans are generally a sign that the company’s leadership believes its stock is undervalued.
About iRhythm Technologies
iRhythm Technologies is a medical technology company that develops digital solutions for detecting and monitoring heart rhythm disorders. Its services combine wearable electrocardiogram (ECG) devices with cloud-based data analysis and clinical reporting to help healthcare professionals assess patients for conditions such as cardiac arrhythmias. The company’s Zio product line includes wearable ECG monitors, such as Zio XT, which records a patient’s heart activity during an extended monitoring period. iRhythm also offers Zio AT, a monitoring service designed to provide clinicians with ECG data during the monitoring period.
Featured Stories
- Five stocks we like better than iRhythm Technologies
- MarketBeat Week in Review – 11/16 – 11/20
- Survey Reveals: How Much Would People Pay for Ribeye Before Giving It Up? [2026]
- If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel It
- 3 Dividend ETFs Offering Steadier Footing in a Shaky Market
Want to see what other hedge funds are holding IRTC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iRhythm Technologies (NASDAQ:IRTC – Free Report).
Receive News & Ratings for iRhythm Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iRhythm Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
